Abstract
Vascular endothelial growth factor (VEGF) demonstrates potent and well-characterized effects on endothelial cytoprotection and angiogenesis. In an attempt to preserve spinal microvasculature and prolong the endogenous neovascular response observed transiently following experimental spinal cord injury (SCI), exogenous recombinant human VEGF (rhVEGF165) was injected into the injured rat spinal cord. Adult female Fischer 344 rats were subjected to moderate SCI (12.5 g-cm) using the NYU impactor. At 72 h after injury, animals were randomly assigned to three experimental groups receiving no microinjection or injection of saline or saline containing 2 μg of rhVEGF165. Acutely, VEGF injection resulted in significant microvascular permeability and infiltration of leukocytes into spinal cord parenchyma. 6 weeks postinjection, no significant differences were observed in most measures of microvascular architecture following VEGF treatment, but analysis of histopathology in spinal cord tissue revealed profound exacerbation of lesion volume. These results support the idea that intraparenchymal application of the proangiogenic factor VEGF may exacerbate SCI, likely through its effect on vessel permeability.
Similar content being viewed by others
REFERENCES
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. 1983. Tumor-cells secrete a vascular-permeability factor that promotes accumulation of ascites-fluid. Science 219:983-985.
Robinson, C. J. and Stringer, S. E. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114:853-865.
Dvorak, H. F. 2000. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24:75-78.
Miao, H. Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A., and Klagsbrun, M. 1999. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146:233-242.
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745.
Carmeliet, P. and Storkebaum, E. 2002. Vascular and neuronal effects of VEGF in the nervous system: Implications for neurological disorders. Semin. Cell Dev. Biol. 13:39-53.
Baek, J. H., Jang, J. E., Kang, C. M., Chung, H. Y., Kim, N. D., and Kim, K. W. 2000. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19:4621-4631.
Jin, K. L., Mao, X. O., and Greenberg, D. A. 2000. Vascular endothelial growth factor: Direct neuroprotective effect in vitro ischemia. Proc. Natl. Acad. Sci. USA 97:10242-10247.
Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., and Tohyama, M. 2001. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: Signal transduction cascades. FASEB J. 15:1218-1220.
Svensson, B., Peters, M., Konig, H. G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, T., Kogel, D., and Prehn, J. H. M. 2002. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 22:1170-1175.
Kawakami, A., Kitsukawa, T., Takagi, S., and Fujisawa, H. 1996. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J. Neurobiol. 29:1-17.
Jin, K. L., Zhu, Y. H., Sun, Y. J., Mao, X. O., Xie, L., and Greenberg, D. A. 2002. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 99:11946-11950.
Zhu, Y., Jin, K., Mao, X. O., and Greenberg, D. A. 2003. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. FASEB J. 17:186-193.
Tator, C. H., and Fehlings, M. G. 1991. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75:15-26.
Dohrmann, G. J., Wagner, F. C., and Bucy, P. C. 1971. Microvasculature in transitory traumatic paraplegia: Electron microscopic study in monkey. J. Neurosurg. 35:263-271.
Griffiths, I. R., Burns, N., and Crawford, A. R. 1978. Early vascular changes in the spinal grey matter following impact injury. Acta Neuropathol. (Berl.) 41:33-39.
Bilgen, M. and Narayana, P. A. 2001. A pharmacokinetic model for quantitative evaluation of spinal cord injury with dynamic contrast-enhanced magnetic resonance imaging. Magn. Reson. Med. 46:1099-1106.
Beggs, J. L. and Waggener, J. D. 1979. Microvascular regeneration following spinal cord injury: The growth sequence and permeability properties of new vessels. Adv. Neurol. 22: 191-206.
Popovich, P. G., Horner, P. J., Mullin, B. B., and Stokes, B. T. 1996. A quantitative spatial analysis of the blood-spinal cord barrier: I Permeability changes after experimental spinal contusion injury. Exp. Neurol. 142:258-275.
Holtz, A., Nystrom, B., and Gerdin, B. 1990. Relation between spinal cord blood flow and functional recovery after blocking weight-induced spinal cord injury in rats. Neurosurgery 26:952-957.
Blight, A. R. 1991. Morphometric analysis of blood vessels in chronic experimental spinal cord injury: Hypervascularity and recovery of function. J. Neurol. Sci. 106:158-174.
Casella, G. T., Marcillo, A., Bunge, M. B., and Wood, P. M. 2002. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp. Neurol 173:63-76.
Imperato-Kalmar, E. L., McKinney, R. A., Schnell, L., Rubin, B. P., and Schwab, M. E. 1997. Local changes in vascular architecture following partial spinal cord lesion in the rat. Exp. Neurol. 145:322-328.
Loy, D. N., Crawford, C. H., Darnall, J. B., Burke, D. A., Onifer, S. M., and Whittemore, S. R. 2002. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 445:308-324.
Bartholdi, D., Rubin, B. P., and Schwab, M. E. 1997. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 9:2549-2560.
Vaquero, J., Zurita, M., de Oya, S., and Coca, S. 1999. Vascular endothelial growth/permeability factor in spinal cord injury. J. Neurosurg. 90:220-223.
Hayashi, T., Sakurai, M., Abe, K., Sadahiro, M., Tabayashi, K., and Itoyama, Y. 1999. Expression of angiogenic factors in rabbit spinal cord after transient ischaemia. Neuropathol. Appl. Neurobiol. 25:63-71.
Kovacs, Z., Ikezaki, K., Samoto, K., Inamura, T., and Fukui, M. 1996. VEGF and flt: Expression time kinetics in rat brain infarct. Stroke 27:1865-1872.
Ogunshola, O. O., Stewart, W. B., Mihalcik, V., Solli, T., Madri, J. A., and Ment, L. R. 2000. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain Res. 119:139-153.
Salhia, B., Angelov, L., Roncari, L., Wu, X., Shannon, P., and Guha, A. 2000. Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res. 883:87-97.
Facchiano, F., Fernandez, E., Mancarella, S., Maira, G., Miscusi, M., D'Arcangelo, D., Cimino-Reale, G., Falchetti, M. L., Capogrossi, M. C., and Pallini, R. 2002. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg. 97:161-168.
Wamil, A. W., Wamil, B. D., and Hellerqvist, C. G. 1998. CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury. Proc. Natl. Acad. Sci. USA 95:13188-13193.
Shubik, P., Feldman, R., Garcia, H., and Warren, B. A. 1976. Vascularization induced in the cheek pouch of the Syrian hamster by tumor and nontumor substances. J. Natl. Cancer Inst 57:769-774.
Gruner, J. A. 1992. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma. 9:123-126.
Magnuson, D. S. K., Trinder, T. C., Zhang, Y. P., Burke, D., Morassutti, D. J., and Shields, C. B. 1999. Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat. Exp. Neurol. 156:191-204.
Cao, Q. L., Zhang, Y. P., Howard, R. M., Walters, W. M., Tsoulfas, P., and Whittemore, S. R. 2001. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol 167:48-58.
Cao, Q. L., Howard, R. M., Dennison, J. B., and Whittemore, S. R. 2002. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol. 177:349-359.
Loy, D. N., Magnuson, D. S., Zhang, Y. P., Onifer, S. M., Mills, M. D., Cao, Q. L., Darnall, J. B., Fajardo, L. C., Burke, D. A., and Whittemore, S. R. 2002. Functional redundancy of ventral spinal locomotor pathways. J. Neurosci. 22:315-323.
Westmark, R., Noble, L. J., Fukuda, K., Aihara, N., and McKenzie, A. L. 1995. Intrathecal administration of endothelin-1 in the rat: Impact on spinal cord blood flow and the blood-spinal cord barrier. Neurosci. Lett. 192:173-176.
Benton, R. L., Ross, C. D., and Miller, K. E. 2001. Spinal taurine levels are increased 7 and 30 days following methylprednisolone treatment of spinal cord injury in rats. Brain Res. 893:292-300.
Silverman, W. F., Krum, J. M., Mani, N., and Rosenstein, J. M. 1999. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 90:1529-1541.
Skold, M., Cullheim, S., Hammarberg, H., Piehl, F., Suneson, A., Lake, S., Sjogren, A., Walum, E., and Risling, M. 2000. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12:3675-3686.
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R. L., Davies, K., Powers, C., van Bruggen, N. and Chopp, M. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106:829-838.
Krum, J. M., Mani, N., and Rosenstein, J. M. 2002. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110: 589-604.
Casper, D., Engstrom, S. J., Mirchandani, G. R., Pidel, A., Palencia, D., Cho, P. H., Brownlee, M., Edelstein, D., Federoff, H. J., and Sonstein, W. J. 2002. Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer. Cell Transplant. 11:331-349.
Esiri, M. M. and Gay, D. 1990. Immunological and neuropathological significance of the Virchow-Robin space. J. Neurol. Sci. 100:3-8.
Fitch, M. T., Doller, C., Combs, C. K., Landreth, G. E., and Silver, J. 1999. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19:8182-8198.
Cheng, S. Y., Nagane, M., Huang, H. J. S., and Cavenee, W. K. 1997. Intracerebral tumor-associated hemorrhage caused by over-expression of the vascular endothelial growth factor isoforms VEGF(121) and VEGF(165) but not VEGF(189). Proc. Natl. Acad. Sci. USA 94:12081-12087.
Otomo, E. 1968. The vascular system and blood flow of the spinal cord. Trans. Am. Neurol. Assoc. 93:260-261.
Jaeger, C. B. and Blight, A. R. 1997. Spinal cord compression injury in guinea pigs: Structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair. Exp. Neurol. 144:381-399.
Noble, L. J. and Wrathall, J. R. 1989. Distribution and time course of protein extravasation in the rat spinal-cord after contusive injury. Brain Res. 482:57-66.
Sasaki, S., Schneider, H., and Renz, S. 1978. Microcirculatory disturbances during the early phase following experimental spinal cord trauma in the rat. Adv. Neurol. 20:423-431.
Proescholdt, M. A., Heiss, J. D., Walbridge, S., Muhlhauser, J., Capogrossi, M. C., Oldfield, E. H., and Merrill, M. J. 1999. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J. Neuropathol. Exp. Neurol. 58:613-627.
Marumo, T., Schini-Kerth, V. B., and Busse, R. 1999. Vascular endothelial growth factor activates nuclear factor-kappa B and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48:1131-1137.
Lee, T. H., Avraham, H., Lee, S. H., and Avraham, S. 2002. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 277: 10445-10451.
Bartholdi, D. and Schwab, M. E. 1995. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:177-186.
Taoka, Y. and Okajima, K. 1998. Spinal cord injury in the rat. Prog. Neurobiol. 56:341-358.
Proescholdt, M. A., Jacobson, S., Tresser, N., Oldfield, E. H., and Merrill, M. J. 2002. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 61:914-925.
Mabon, P. J., Weaver, L. C., and Dekaban, G. A. 2000. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alpha D: A potential new anti-inflammatory treatment. Exp. Neurol. 166:52-64.
Tonai, T., Shiba, K., Taketani, Y., Ohmoto, Y., Murata, K., Muraguchi, M., Ohsaki, H., Takeda, E., and Nishisho, T. 2001. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J. Neurochem. 78: 1064-1072.
Forstreuter, F., Lucius, R., and Mentlein, R. 2002. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J. Neuroimmunol. 132:93-98.
Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., and Marme, D. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343.
Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J., and Risau, W. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271: 17629-17634.
Bethea, J. R. and Dietrich, W. D. 2002. Targeting the host inflammatory response in traumatic spinal cord injury. Curr. Opin. Neurol. 15:355-360.
Popovich, P. G., Guan, Z., McGaughy, V., Fisher, L., Hickey, W. F., and Basso, D. M. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61:623-633.
Popovich, P. G., Guan, Z., Wei, P., Huitinga, I., van Rooijen, N., and Stokes, B. T. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158:351-365.
Thurston, G. 2002. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J. Anat. 200: 575-580.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benton, R.L., Whittemore, S.R. VEGF165 Therapy Exacerbates Secondary Damage Following Spinal Cord Injury. Neurochem Res 28, 1693–1703 (2003). https://doi.org/10.1023/A:1026013106016
Issue Date:
DOI: https://doi.org/10.1023/A:1026013106016